Systematic monitoring of adverse effects is essential for neuromodulation studies, yet standardized tools are limited. The NIBS-SES provides a single, harmonized instrument applicable to TMS, tES, and tUS to support transparent, comparable, and synthesis-ready safety reporting.
• Cross-modality: one harmonized questionnaire usable for TMS, tES (tDCS/tACS), and tUS
• Repeated-measure: suitable for routine session-by-session monitoring
• Coverage: includes both highly prevalent and less common adverse effects
• Timeframe distinction: separates sensations during stimulation from effects between sessions
• Usability: revised via expert review for clarity, structure, and layout
• Availability: Professional translations for in 15 languages
All versions can be downloaded on the OSF repository
TBA
Professional prepared and reviewed by field experts for conceptual accuracy for Arabic, Basque, Catalan, Dutch, French, Galician, German, Hindi, Italian, Japanese, Korean, Mandarin Chinese, Persian, Portuguese, Spanish. Covering the most widely spoken languages as well as the most active noninvasive brain stimulation communities worldwide. All translations were reviewed for conceptual accuracy by field experts.
In addition to a paper-and-pencil version, digital implementations are available via Qualtrics and SoSci Survey.
Development combined empirical session data and structured literature review of adverse effects across TMS, tES, and tUS. An initial item pool was informed by 851 TMS sessions and adverse effects reported in the literature. The questionnaire was refined using structured expert ratings and open-ended feedback. Psychometric analyses supported feasibility for repeated administration and indicated stable reporting patterns for acute side-effect items across temporally adjacent sessions. The final NIBS-SES distinguishes effects occurring during stimulation from those occurring between sessions.
Suggested Methods text (copy/paste):
BibTeX (copy/paste):
@article{...}
If you use the NIBS-SES in any publication, thesis, preprint, or protocol, please cite the associated paper. Provide the citation (APA) and BibTeX on this page for copy/paste, and consider using the suggested Methods sentence. If you create a translation or adapted version, please cite the original NIBS-SES in addition to your derived version.
The NIBS-SES is licensed under CC BY 4.0. You may use, share, adapt, and translate the questionnaire for research or clinical purposes, including in publications and study protocols, as long as you give appropriate credit and cite the original publication/source.
Dr. Benjamin Selaskowski
Institute for Network Stimulation
University Hospital Cologne
benjamin.selaskowski@uk-koeln.de
Dr. Maximilian Kiebs
Head Brain-Stimulation Research Group
Department of Psychiatry and Psychotherapy
School of Medicine & Health Sciences
Carl von Ossietzky University of Oldenburg